Cargando…
DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design
Since the outbreak of SARS-CoV-2, numerous compounds against COVID-19 have been derived by computer-aided drug design (CADD) studies. They are valuable resources for the development of COVID-19 therapeutics. In this work, we reviewed these studies and analyzed 779 compounds against 16 target protein...
Autores principales: | Liu, Yang, Gan, Jianhong, Wang, Rongqi, Yang, Xiaocong, Xiao, Zhixiong, Cao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838031/ https://www.ncbi.nlm.nih.gov/pubmed/35163948 http://dx.doi.org/10.3390/molecules27030683 |
Ejemplares similares
-
A review on computer‐aided chemogenomics and drug repositioning for rational COVID‐19 drug discovery
por: Maghsoudi, Saeid, et al.
Publicado: (2022) -
An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19
por: Gurung, Arun Bahadur, et al.
Publicado: (2021) -
Basis to Aid Crisis: Favipiravir Oral Solution for Hospital Compounding During COVID-19 Drug Shortage
por: Tuesuwan, Bodin, et al.
Publicado: (2023) -
A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials
por: Mongia, Aanchal, et al.
Publicado: (2021) -
Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment
por: Shehroz, Muhammad, et al.
Publicado: (2020)